A Study to Determine the Efficacy of a Digital Self-management Support Tool to Improve the Quality of Life During Adjuvant HOrmonal Therapy for Patients With Early Breast Cancer

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

April 15, 2025

Primary Completion Date

March 15, 2026

Study Completion Date

December 15, 2026

Conditions
Breast CancerBreast Cancer Early Stage Breast Cancer (Stage 1-3)
Interventions
OTHER

multimodal Resilience© digital companion

"Resilience© is a multi-component, multi-level interventional mobile application that will offer: (a) supportive educational care information (b) self-symptom management resources with availability of a remote health-care provider evaluation that addresses patient-specific needs in survivorship care and recommends personalized digital self-management resources at onboarding and if needed in case of low engagement in the mobile app.~Intervention duration : 3 weeks"

OTHER

Standard supportive care

standard of care provided by the oncologist and supportive care team at the patient local cancer center including referrals for local supportive care programs. Local supportive care programs may also include the use of already deployed remote patient monitoring and solutions, digital and in person education.

Trial Locations (1)

Unknown

Gustave Roussy, Villejuif

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Resilience

INDUSTRY

collaborator

WeShare

UNKNOWN

collaborator

National Cancer Institute, France

OTHER_GOV

lead

Gustave Roussy, Cancer Campus, Grand Paris

OTHER